z-logo
Premium
Biosimilars: is interchangeability the proof of the pudding?
Author(s) -
Moore Gregory T,
Keung Charlotte
Publication year - 2021
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja2.50912
Subject(s) - interchangeability , citation , library science , computer science , programming language
Biologic drugs are large monoclonal antibodies or genetically engineered proteins produced by live organisms. With highly specific targets, they have revolutionised the treatment of inflammatory, endocrine, and malignant conditions. However, these drugs are expensive, partly because of the complex and costly manufacturing processes required, partly because long periods of therapy are often needed.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here